The pharmacogenomics of pain management: prospects for personalized medicine

• Main Authors: Ting S, Schug S
• Format: Article
• Language: English
• Published: Dove Medical Press 2016-02-01
• Series: Journal of Pain Research
• Subjects: Pharmacogenomics; pain; opioids; NSAIDs; cytochrome P450; ethnicity
• Online Access: https://www.dovepress.com/the-pharmacogenomics-of-pain-management-prospects-for-personalized-med-peer-reviewed-article-JPR
• ISSN: 1178-7090

Sonya Ting,1 Stephan Schug2,3 1Department of Anaesthesia, Sir Charles Gairdner Hospital, Perth, WA, Australia; 2Anaesthesiology Unit, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; 3Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, University of Western Australia Anaesthesiology Unit, Royal Perth Hospital, Perth, WA, Australia Abstract: Pain is a common symptom that can be complex to treat. Analgesic medications are the mainstay treatment, but there is wide interindividual variability in analgesic response and adverse effects. Pharmacogenomics is the study of inherited genetic traits that result in these individual responses to drugs. This narrative review will attempt to cover the current understanding of the pharmacogenomics of pain, examining common genes affecting metabolism of analgesic medications, their distribution throughout the body, and end organ effects. Keywords: cytochrome P450, COMT, pharmacokinetics, pharmacodynamics, inherited traits